Skip to main content

Table 1 Sociodemographic, clinical, and general characteristics of the pneumonic process caused by COVID-19 in the patients included in the study

From: Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value

Variables

Total

Demografics and clinics before admission

N = 194

Male sex, N (%),

114 (55.8)

Age, years

62 (51.5–71)

Body mass index (Kg/m2)

29 (26–32)

Previous and current smoker, N (%)

78 (40.2)

History of chronic cardiopathy, N (%)

36 (18.6)

History of diabetes, N (%)

21 (10.8)

History of hypertension, N (%)

71 (36.6)

History of COPD, N (%)

13 (6.7)

History of chronic kidney failure, N (%)

6 (3.1)

ECOG score

1 (1–2)

ECOG score ≥ 2, N (%)

51 (26.2)

In relation to the pneumonic process

N = 194

Bilateral radiographic involvement, N (%)

149 (76.8)

Oxygen saturation at hospital admission

92 (89–97)

Pneumonia Severity Index

61 (50–71)

Pneumonia Severity Index ≥ 3, N (%)

62 (31.9)

ICU admission, N (%)

33 (17)

Invasive mechanical ventilation, N (%)

26 (13.4)

Maximum level of lactate deshydrogenase (U/L)

294 (230–386.5)

Maximum level of D-dimer (ng/mL)

1040 (486.5–2544.5)

Length of stay (days)

7 (4–13.2)

  1. Median (25th and 75th percentile)
  2. COPD chronic obstructive pulmonary disease, ECOG Eastern Cooperative Oncology Group, ICU intensive care unit